Background strain: | cMJ030 | Click here to order this strain from the Chlamydomonas Resource Center. The background strain comes free with every order. |
Transformation condition: | RY0402 | |
Antibiotic resistance: | resistant to paromomycin |
Insertion junctions | |||||
Insertion junction | Locus systematic id | Locus common name | Defline | Feature | Confidence (%) |
---|---|---|---|---|---|
LMJ.RY0402.131757_1 | Cre10.g467200 | ATR1 | (1 of 2) PTHR11139:SF69 - SERINE/THREONINE-PROTEIN KINASE ATR; ATM/ATR-related phosphatidylinositol 3-kinase | intron | 73 |
If you use this mutant for your work, please cite: Li et al. 2019 Nature Genetics.
This mutant exhibited a phenotype under the following conditions:
Bleomycin sulfate, screen 2 of 2 (No phenotype detected) |
Cisplatin, screen 1 of 4 (No growth detected) |
Cisplatin, screen 2 of 4 (~80.0% growth defect) |
Cisplatin, screen 3 of 4 (~70.0% growth defect) |
Cisplatin, screen 4 of 4 (~90.0% growth defect) |
Hydroxyurea, screen 2 of 2 (~70.0% growth defect) |
Methyl methanesulfonate, screen 1 of 4 (~30.0% growth defect) |
Methyl methanesulfonate, screen 2 of 4 (~30.0% growth defect) |
Methyl methanesulfonate, screen 3 of 4 (~70.0% growth defect) |
Methyl methanesulfonate, screen 4 of 4 (~50.0% growth defect) |
Mitomycin C, screen 1 of 4 (~20.0% growth defect) |
Mitomycin C, screen 2 of 4 (~10.0% growth defect) |
Mitomycin C, screen 3 of 4 (No phenotype detected) |
Mitomycin C, screen 4 of 4 (~10.0% growth defect) |
Zeocin, screen 1 of 5 (No phenotype detected) |
Zeocin, screen 3 of 5 (~10.0% growth defect) |
Zeocin, screen 4 of 5 (~10.0% growth defect) |
Zeocin, screen 5 of 5 (~10.0% growth defect) |
Note: Not all phenotypes can be confidently associated with a specific gene or insertion; phenotypes can be caused by unmapped second-site mutations. Please see the gene pages for statistically significant gene-phenotype links. These data are from a pooled phenotyping experiment.
If you reference the phenotypic data above in a manuscript, please cite: Fauser et al. 2022 Nature Genetics.